Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where remedy alternatives remain limited. Use the links below to learn a lot more about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/foresight-ventures-participates-in-10m-series-a-investment-round-of-august/